Clinical Trial

Breast 3DUS ABUS System Comparison

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
This comparative study will recruit 30 females who are scheduled for mammography and ultrasound assessment. The clinical 2D ultrasound is performed routinely, and the research portion of this study will add a few extra 3-D ultrasound images during the procedure. The ultrasound imaging laboratory under the direction of Dr. Aaron Fenster has developed a customized device designed to acquire 3D ultrasound of the breast using a commercial ultrasound machine. The purpose is to see how well 3-dimensional ultrasound acquire from that device is able to visualize tumours and other key features in comparison to the clinical system InveniaTM developed by GE Medical.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-31; most recent amendment 2025-04-09.
Status change: Not Yet Recruiting → Recruiting 2025-04-09
Trial Details
NCT Number NCT06118996
Lead Sponsor Western University, Canada
Conditions Breast Diseases
Enrollment 30 participants
Start Date 2024-08-18
Primary Completion 2026-04 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-13